Literature DB >> 8245006

The transactivation potential of variant hepatocyte nuclear factor 1 is modified by alternative splicing.

F Ringeisen1, J Rey-Campos, M Yaniv.   

Abstract

Two forms of the transcription factor vHNF1 (HNF1 beta or LFB3) have been previously described, derived by alternative splicing from a common premessenger RNA, and have been called vHNF1-A and vHNF1-B. vHNF1 proteins share a homologous homeo-related DNA-binding domain with the HNF1 protein, initially characterized as a liver-restricted transcription factor, and bind to a similar sequence motif. Here we demonstrate that vHNF1-A is a stronger transactivator than vHNF1-B when assayed in transient transfections using two different promoters. vHNF1-A also binds DNA with a higher affinity suggesting that a region of the protein located immediately upstream of the homeodomain can modulate the protein/DNA interaction and transactivation. Both vHNF1 transcripts were found at a constant ratio in every tissue where vHNF1 expression could be detected, using a quantitative reverse transcriptase-polymerase chain reaction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8245006

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  NR2F1 disrupts synergistic activation of the MTTP gene transcription by HNF-4α and HNF-1α.

Authors:  Kezhi Dai; M Mahmood Hussain
Journal:  J Lipid Res       Date:  2012-02-22       Impact factor: 5.922

2.  Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation.

Authors:  J Li; V E Buckwold; M W Hon; J H Ou
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

3.  Application of multivariate statistical procedures to identify transcription factors that correlate with MRP2, 3, and 4 mRNA in adult human livers.

Authors:  L M Aleksunes; R L Yeager; C D Klaassen
Journal:  Xenobiotica       Date:  2009-07       Impact factor: 1.908

4.  Role of tissue-specific transcription factor LFB3 in a cyclic AMP-responsive enhancer of the urokinase-type plasminogen activator gene in LLC-PK1 cells.

Authors:  M K Soubt; R Marksitzer; P A Menoud; Y Nagamine
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.